BIMI International Medical Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BIMI research report →
Companywww.usbimi.com/index.html
BIMI International Medical Inc. , together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies.
- CEO
- Tiewei Song
- IPO
- 2006
- Employees
- 296
- HQ
- Chongqing, CN
Price Chart
Valuation
- Market Cap
- $1.16K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.17
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 16.48%
- Op Margin
- -129.65%
- Net Margin
- -189.29%
- ROE
- -293.85%
- ROIC
- -118.73%
Growth & Income
- Revenue
- $11.83M · -44.51%
- Net Income
- $-22,393,000 · 35.99%
- EPS
- $-8.40 · 87.10%
- Op Income
- $-15,338,000
- FCF YoY
- -390.58%
Performance & Tape
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.57
- Avg Volume
- 515
Get TickerSpark's AI analysis on BIMI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 12, 24 | Oudom Fnu | other | 1,123,500 |
| Dec 29, 23 | Smith Symington Wei | other | 0 |
| Feb 26, 24 | Tiewei Song | sell | 724 |
| Feb 28, 24 | Tiewei Song | sell | 4,000 |
| Jan 2, 24 | Oudom Fnu | other | 2,000,000 |
| Dec 28, 23 | Oudom Fnu | other | 214,044 |
| Dec 28, 23 | Oudom Fnu | other | 200,000 |
| Dec 6, 23 | Oudom Fnu | other | 5,000,000 |
| Jun 19, 23 | Oudom Fnu | other | 270,000 |
| Jun 19, 23 | Oudom Fnu | other | 1,330,000 |
Our BIMI Coverage
We haven't published any research on BIMI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BIMI Report →